timothy sykes logo

Stock News

Oscar Health Faces Investigation: What It Means for Stocks

Ellis HobbsAvatar
Written by Ellis Hobbs

Oscar Health Inc. faces significant market impact from news of a $98.5 million loss reported in Q2, heightening concerns among investors, leading to shares trading down by -8.0 percent on Thursday.

Recent Allegations Against Oscar Health

  • Amidst rising market fluctuations, Oscar Health faces criticism for allegedly misusing the No Surprises Act to delay payments and underpaying California health systems. A recent report from The Capitol Forum brings these allegations to light, shaking investor confidence in the company’s practices.

Candlestick Chart

Live Update At 11:37:47 EST: On Thursday, March 13, 2025 Oscar Health Inc. stock [NYSE: OSCR] is trending down by -8.0%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

  • Investigations are currently underway to scrutinize Oscar Health, Inc. for potential securities fraud, involving misleading statements and the non-disclosure of critical information. These revelations have significantly impacted the company’s stock value.

Oscar Health Inc.’s Stock Plummet: Analysis and Reaction

As any seasoned trader would attest, the stock market is as much an arena for mental discipline as it is for shrewd analysis. It’s not uncommon for traders to face volatility and uncertainty, often testing their resolve and prompting them to act on impulse. This is where the wisdom of maintaining a steadfast approach becomes invaluable. As millionaire penny stock trader and teacher Tim Sykes says, “Preparation plus patience leads to big profits.” Understanding this principle can guide traders through the turbulent waters of the market, ensuring that they focus on thorough research and strategic timing. By cultivating patience along with comprehensive preparation, traders can ultimately achieve significant gains amidst the unpredictability.

In the ever-dynamic world of stock trading, shares can plunge just as fast as they can soar, and Oscar Health Inc. is a prime example of this volatility.

Allegations concerning the misuse of the No Surprises Act have surfaced against Oscar Health. Reports suggest that the company may have been executing unfair tactics, delaying significant payments to several health systems in California. The Capitol Forum brought this to light in an article dated Feb 12, 2025, causing unease among stakeholders.

More Breaking News

Not far behind, on Feb 13, 2025, an investigation against Oscar Health, Inc. for potential securities fraud was reported. This looked into misleading claims and critical undisclosed info that might have contributed to a notable decrease in stock prices. These controversies have led to growing concerns among investors who are starting to wonder about the potential implications for the company’s future.

Quick Overview of Oscar Health Inc.’s Recent Earnings Report

Oscar Health Inc., identified by the ticker symbol OSCR, has been navigating a financial storm recently. As of Mar 13, 2025, the stock opened at $13.6 and closed close at $13.07, dropping from a high of $16.56 on Mar 07. This is a part of a string of fluctuations starting early Feb 2025.

The latest earnings report for Oscar Health showed a change in cash flow with an increase of about $319.19M despite some operating losses of $0.025M. The firm’s pricing-to-free cash flow (at 2.6) and price-to-sales ratio of 0.39 paint a picture of its value against revenue. Compared to five years ago, when the company also recorded a markedly high pre-tax profit margin of -8%, the evolution is noteworthy.

On a personal note, it reminds me of when I was first navigating the uncertain tides of investment—each rise and dip in stock prices felt like watching a heart monitor, ticking away unpredictably. It’s like being on a rollercoaster, thrilling but always keeping you on your toes. Just as I took cautious steps, one should evaluate whether OSCR’s current pricing and future outlook meet their investment appetite.

Conclusion: Oscar Health – Should You Buy or Wait?

With scrutiny looming over Oscar Health, the circumstances pose questions for both traders and stakeholders. Whether to ride the wave or sit this one out becomes the vibrant discussion on Wall Street as the stock faces turbulent times. While such challenges are not uncommon for rising firms, the market is often unforgiving, making it crucial to keep a watchful eye on developments and tread carefully. As millionaire penny stock trader and teacher Tim Sykes says, “The goal is not to win every trade but to protect your capital and keep moving forward.” It’s critical in scenarios like these to navigate with insight, foresight and caution—always mindful of the dynamic nature of markets.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:


How much has this post helped you?


Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”